Genizon BioSciences, Inc. announced that it has received CAD 12.40 million in funding from Bio Fund Management Ltd., Carnegie Investment Bank AB, Asset Management Arm, HBM Partners Ltd., Illumina Inc., MVI Group, and other investors..
"Genizon BioSciences, Inc. announced a private placement of secured convertible debentures for gross proceeds CAD 12.4 million on March 29, 2006. Existing investors HBM BioVentures AG, managed by HBM Partners Ltd.; Bio Fund Management Ltd.; MVI Finance; and Carnegie Fund II along with new investor Illumina Inc.; private investors; and management, board members, and employees of Genizon BioSciences, Inc. participated in the transaction. On March 29, 2006, Genizon BioSciences, Inc. closed the transaction."
